PREVINQ-WARM: Study on the Incidence of Perioperative Hypothermia at the Surgical Area of Parc Tauli Hospital Universitari, Sabadell

Sponsor
Corporacion Parc Tauli (Other)
Overall Status
Completed
CT.gov ID
NCT03961620
Collaborator
3M (Industry)
101
1
31.5
3.2

Study Details

Study Description

Brief Summary

The study TAULÍ-PREVINQ-WARM will assess the rate of perioperative hypothermia in patients submitted to major surgical procedures at the operating room main area (and at the ambulatory surgery building for ophthalmologic major procedures) of the Parc Taulí, Hospital Universitari, Sabadell, Barcelona.

Condition or Disease Intervention/Treatment Phase
  • Device: The SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.

Detailed Description

Treatment plan The month before the start of the study, investigators will double check with the administrative personnel the potential candidates to be included in to the study. Furthermore, investigators will meet with the responsible of each surgical specialty to delineate the adequate staff workload and collaborators needs. To assure the best study performance and to avoid selection patient bias, patients will be consecutively included in blocs of each designated surgical specialty.

At the patient admission area and surgical preparation, associated investigators will inform to candidates and relatives about the project giving the informed form to be signed.

Patient inclusion will include a pilot phase (four to five patients) to teach collaborators regarding the correct placement of cutaneous sensor, data lecture and registration to the database. Along with the maintenance department of the hospital, we also assess the correct installation and function of temperature and humidity sensors at the OR (Mini-datalogger 174H, Instrumentos Testo, S.A. Cabrils, Barcelona). OR temperature and the degree of humidity will be measured at the specific time points stated at the paragraph of the measurements.

Body temperature (BT) measurements will be performed at the UPQ, anesthesia preparation room, OR and URPA in those specifically stated time points (Annex 2 and Figure 1).

Because the investigators want to perform a pragmatic study, patients will receive conventional normothermia preventive measures following the approved local guidelines from the Anesthesiology Department.

Measurement and data entry Body temperature (BT) Patient's BT will be assessed with the SpotOn system that encompasses the registration unit (3M SpotOn Control Unit), disposable sensor (3M SpotOn Control Sensor) along with the cords and electric power unit.

Non-invasive digital BT system monitorization SpotOn, includes a sensor that by adhering to the lateral side of supra-ocular region, allows for continued registration of BT for the overall surgical process.

Number of times and sites of BT registration Staff devoted to assess BT measurements. Staff from 3M, will advise nurses, anesthesiologists and investigators regarding SpotOn specifications and management at the beginning of the study

Because OR temperature and degree of humidity may have some influence on patient's BT and thermic comfort both patients and OR staff, OR temperature and humidity will be registered at the beginning and at the end of surgical procedure. Also, the protocol will take in to the account weather conditions registered at the MeteoCat and will be included at the data base regularly. Also, staff from Maintenance of Hospital Facilities and Equipment, will set up and store data from the OR temperature and humidity sensors (Mini-datalogger 174H, Instrumentos Testo, S.A. Cabrils, Barcelona).

Data about measures addressed to sustain perioperative normothermia will also be recorded (see Annex 4)

At the end of surgical procedure the investigators will ask patients and OR staff for running a visual analogic scale punctuation (1 to 10) regarding the perceived thermal comfort (see Annex 5)

Length of the study and period of patients recruitment. Because the specific nature of this prospective observational and pragmatic study, the rate of patients recruitment will be assessed frequently to accommodate both optimal patient accrual and fair and adequate entry data. The approximate time for total patients inclusion will be of one year.

Sample size The main objective of the study TAULI-PREVINQ-WARM is to assess the rate of perioperative hypothermia (<36ªC) at some point during the surgical process in patients operated on for a major surgical procedure at the Parc Tauli, Hospital Universitari, Sabadell. Then, sample size has been calculated taking in to the account that roughly 50% of patients will have some kind of hypothermia with 10% of variability of 95% CI. Assuming a10% of repository additional patients, 110 patients will be included overall.

Assessment of data results and statistical analysis. The TAULI-PREVINQ-WARM is a pragmatic study that wants to assess body temperature in surgical patients under regular clinical conditions. We will perform a descriptive analysis of data by depicting mainly frequency distribution analysis of the qualitative main variable, HypoTer. The proposed sample size will allow also for assessing the rate HypoTer at each different surgical areas where patients are admitted. Also, repeated measures will be compared among different surgical procedures at the OR taking in to consideration the body surface area under regular preventive normothermia measures, following the general lineal model. Univariate two-sided analysis will be perform for all comparisons and parametric or non-parametric analysis will be performed accordingly. Multivariate analysis might eventually be performed depending of the rate of events.

Study Design

Study Type:
Observational
Actual Enrollment :
101 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prospective Observational Study on the Incidence of Perioperative Hypothermia and the Effect of Standard Normothermia Measures at the Surgical Area of Parc Tauli Hospital Universitari, Sabadell: Tauli-Previnq-Warm
Actual Study Start Date :
Jul 9, 2019
Actual Primary Completion Date :
Dec 30, 2021
Actual Study Completion Date :
Feb 22, 2022

Outcome Measures

Primary Outcome Measures

  1. Rate of perioperative hypothermia (<36ºC) [12 hours]

    Body temperature measured by SpotOn system sensor in different surgical procedures and at any specific surgical area.

Secondary Outcome Measures

  1. Type and duration of applied physical measures to prevent periopertive hypothermia [12 hours]

    The investigators will corroborate whether or not textile blankets, forced air warming blankets or additional measures are applied, anf if so, the time and durations of such measures.

  2. Temperature at the operating room [1-6 hours]

    Temperature and degree of humidity at the OR

  3. Thermal confort [1-6 hours]

    Thermal comfort of patients and OR staff members

  4. Adverse events [Up to 30 days (1 year for prosthetic surgery)]

    Rate of postoperative adverse events

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA score I to IV

  • Patients submitted to major surgical procedures at the main OR facilities (or at the ambulatory surgery building for ophthalmologic procedures) under general or neuraxial anesthesia from surgical specialties

  • Patients (parents or legal guardians regarding pediatric patients) that have signed informed consent form.

Exclusion Criteria:
  • Patients submitted to craniofacial neurosurgical procedures

  • Patients submitted to any surgical procedure requiring draping or sterile isolation of the frontal part of head, precluding intraoperative assessment of SpotOn sensor.

  • Patients (parents or legal guardians regarding pediatric patients) that have not signed informed consent form.

  • Patients that by the time of the hospital admission present a relevant inflammatory or infectious process at the skin of frontal part of the head

  • Patients diagnosed with psychiatric disease relevant enough to avoid adequate staff-patients communication for this specific study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Parc Tauli Hospital Universitari Sabadell Barcelona Spain 08208

Sponsors and Collaborators

  • Corporacion Parc Tauli
  • 3M

Investigators

  • Principal Investigator: Xavier Guirao, MD, Parc Tauli Hospital Universitari, Sabadell

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xavier Guirao, Coordinator of Endocrine, Head and Neck Surgery Unit, Corporacion Parc Tauli
ClinicalTrials.gov Identifier:
NCT03961620
Other Study ID Numbers:
  • 2018/630
First Posted:
May 23, 2019
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Xavier Guirao, Coordinator of Endocrine, Head and Neck Surgery Unit, Corporacion Parc Tauli
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022